Avidity Partners Management LP Scynexis Inc Transaction History
Avidity Partners Management LP
- $2.03 Billion
- Q2 2024
A detailed history of Avidity Partners Management LP transactions in Scynexis Inc stock. As of the latest transaction made, Avidity Partners Management LP holds 1,448,728 shares of SCYX stock, worth $2.22 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,448,728
Previous 1,448,728
-0.0%
Holding current value
$2.22 Million
Previous $2.13 Million
36.07%
% of portfolio
0.14%
Previous 0.08%
Shares
10 transactions
Others Institutions Holding SCYX
# of Institutions
58Shares Held
14.5MCall Options Held
34KPut Options Held
5K-
Federated Hermes, Inc. Pittsburgh, PA4.21MShares$6.45 Million0.02% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$3.42 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$2.58 Million0.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$849,9990.7% of portfolio
-
D.A. Davidson & Co.549KShares$840,3030.01% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $50M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...